UK will limit puberty blockers for gender dysphoria to kids in clinical trials. A document explaining the N.H.S.’s reasoning stated that “there is not enough evidence to support their safety or clinical effectiveness as a routinely available treatment.” https://t.co/IT1tLAFFRC
— Benjamin Ryan (@benryanwriter) June 9, 2023
Saturday, June 10, 2023
UK will limit puberty blockers for gender dysphoria to kids in clinical trials
